issued
on 03 Oct 2023
Last Applicant/ Owned by
5555 OBERLIN DRIVE, SUITE 120
SAN DIEGO
CA
92121
Serial Number
97636703 filed on 18th Oct 2022
Registration Number
N/A
Correspondent Address
Aaron D. Hendelman
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Scientific research and development; research and development of new products in the pharmaceutical and biotechnology fields; research and development of new technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and developmentRead More
Scientific research and development; research and development of new products in the pharmaceutical and biotechnology fields; research and development of new technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of a hypoimmunogenic cell for purposes of providing cell therapy; scientific research and development of technology in the field of cell therapy; scientific testing, inspection, research, and development of pharmaceutical preparations for cell therapy
Pharmaceutical preparations for cell therapy to treat human diseases and disorders; cell therapy products, namely, pharmaceutical preparations to treat cellular disorders, namely, human diseases and disorders
No 97636703
No Service Mark
No 62600-TM1015
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 03rd Oct 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 08th Aug 2023 | PUBLISHED FOR OPPOSITION |
| 08th Aug 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th Jul 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 03rd Jul 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 30th Jun 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 29th Jun 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 29th Jun 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 04th Apr 2023 | NON-FINAL ACTION WRITTEN |
| 04th Apr 2023 | NON-FINAL ACTION E-MAILED |
